Applied Genetic Technologies (AGTC) Tops Q2 EPS by 9c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02, may not compare. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $11.1 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Range Resources (RRC) Tops Q1 EPS by 11c; offers production guidance
• KKR Real Estate Finance Trust (KREF) Tops Q1 EPS by 4c